These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 4960889)

  • 21. Oxidation of tyrosine to dopachrome by peroxidase isolated from murine melanoma.
    Okun MR; Schley L; Ziegelstein R; Blair H
    Physiol Chem Phys; 1982; 14(1):8-12. PubMed ID: 6294694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RELATIONSHIP BETWEEN GROWTH RATE AND DIFFERENTIATION OF MELANOMA IN VIVO.
    GRAY JM; PIERCE GB
    J Natl Cancer Inst; 1964 Jun; 32():1201-10. PubMed ID: 14191394
    [No Abstract]   [Full Text] [Related]  

  • 23. A novel attenuated replication-competent adenovirus for melanoma therapy.
    Peter I; Graf C; Dummer R; Schaffner W; Greber UF; Hemmi S
    Gene Ther; 2003 Apr; 10(7):530-9. PubMed ID: 12646858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultrastructural characterization of a mouse melanoma cell line, a mouse fibroblastic cell line, and hybrids between them.
    Junker S; Chemnitz J
    Eur J Cell Biol; 1981 Apr; 24(1):16-9. PubMed ID: 7238533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific protein production during melanogenesis in B16/C3 melanoma cells.
    Laskin JD; Piccinini L; Engelhardt DL; Weinstein IB
    J Cell Physiol; 1983 Jan; 114(1):68-72. PubMed ID: 6826662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tyrosinase activity and isoenzyme distribution corresponding to growth and regression of melanoma in Sinclair miniature swine.
    Kovacs SA; Geekie KM; Oxenhandler RW; Agris PF
    J Natl Cancer Inst; 1981 Sep; 67(3):645-51. PubMed ID: 6792414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Melanoma-specific cytotoxicity induced by a tyrosinase promoter-enhancer/herpes simplex virus thymidine kinase adenovirus.
    Siders WM; Halloran PJ; Fenton RG
    Cancer Gene Ther; 1998; 5(5):281-91. PubMed ID: 9824047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular detection of circulating tyrosinase mRNA: optimization in a preclinical xenograft mouse melanoma model and further evaluation in samples from advanced melanoma patients.
    Gabri MR; Vazquez V; Girón S; Castro MA; Cinat G; Gomez RE; Santoro FM; Gomez DE; Alonso DF
    Int J Mol Med; 2008 May; 21(5):555-9. PubMed ID: 18425346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of cell division and of tyrosinase in B16 melanoma cells by imidazole: a possible role for the concept of metabolite gene regulation in mammalian cells.
    Montefiori DC; Kline EL
    J Cell Physiol; 1981 Feb; 106(2):283-91. PubMed ID: 6260821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation and characterization of a therapeutic human antibody to melanoma antigen TYRP1.
    Patel D; Balderes P; Lahiji A; Melchior M; Ng S; Bassi R; Wu Y; Griffith H; Jimenez X; Ludwig DL; Hicklin DJ; Kang X
    Hum Antibodies; 2007; 16(3-4):127-36. PubMed ID: 18334748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and degradation of tyrosinase in cultured melanoma cells.
    Saeki H; Oikawa A
    J Cell Physiol; 1980 Aug; 104(2):171-5. PubMed ID: 6773969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decay of hormone responsiveness in mouse melanoma cells in culture as a function of cell density.
    Fuller BB; Lebowitz J
    J Cell Physiol; 1980 May; 103(2):279-87. PubMed ID: 6254996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [ANTITYROSINASE ACTIVITY OF THE SERUM OF PATIENTS WITH MALIGNANT MELANOMA: DEMONSTRATION WITH THE AID OF THE WARBURG APPARATUS].
    GRUPPER C; LEGRAND JC; GONNARD P
    Arch Klin Exp Dermatol; 1964 Jun; 219():784-9. PubMed ID: 14237740
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies on the characterization of tyrosinase of Fusarium vasinfectum Atk.
    Rao KR; Shanmugasundaram ER
    Can J Microbiol; 1967 Apr; 13(4):427-30. PubMed ID: 6034413
    [No Abstract]   [Full Text] [Related]  

  • 35. [First findings apropos of a new strain of mouse highly susceptible to cancer].
    MOURIQUAND J; MOURIQUAND C; PETAT J
    C R Seances Soc Biol Fil; 1960; 154():632-3. PubMed ID: 13773314
    [No Abstract]   [Full Text] [Related]  

  • 36. SOLUBILITY OF PROTYROSINASE AND TYROSINASE.
    Bodine JH; Carlson LD
    Proc Natl Acad Sci U S A; 1954 Jun; 40(6):513-5. PubMed ID: 16589516
    [No Abstract]   [Full Text] [Related]  

  • 37. Molecular analyses of a tyrosinase-negative albino family.
    Park KC; Chintamaneni CD; Halaban R; Witkop CJ; Kwon BS
    Am J Hum Genet; 1993 Feb; 52(2):406-13. PubMed ID: 8430701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of tyrosinase in human melanocytes grown in culture.
    Halaban R; Pomerantz SH; Marshall S; Lambert DT; Lerner AB
    J Cell Biol; 1983 Aug; 97(2):480-8. PubMed ID: 6411733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Control of pigment production in mouse melanoma cells in vitro. Evocation and maintenance.
    Silagi S
    J Cell Biol; 1969 Nov; 43(2):263-74. PubMed ID: 4981070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of pigmentation in mouse melanoma cells by 5-bromodeoxyuridine: effects on tyrosinase activity and melanosome formation.
    Wrathall JR; Oliver C; Silagi S; Essner E
    J Cell Biol; 1973 May; 57(2):406-23. PubMed ID: 4633171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.